arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Computer Science · Artificial Intelligence

Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global

B-cell Dysfunction, Denis J. Moss, A Alan Rickinson, C Henry H. Balfour, E Rajiv Khannaa

See on the map

Abstract

Here we present evidence for previously unappreciated B-cell immune dysregulation during acute Epstein-Barr virus (EBV)-associated infectious mononucleosis (IM). Longitudinal analyses revealed that patients with acute IM have undetectable EBV-specific neutralizing antibodies and gp350-specific B-cell responses, which were associated with a significant reduction in mem-ory B cells and no evidence of circulating antibody-secreting cells. These observations correlate with dysregulation of tumor necrosis factor family members BAFF and APRIL and increased expression of FAS on circulating B cells. Epstein-Barr virus (EBV) is a human herpesvirus that infectsmore than 90 % of the world’s population (1). While benign and asymptomatic for the most part, EBV infection has the poten-tial to cause many nonmalignant and malignant diseases of lym-phoid and epithelial origins (2). EBV infection during childhood is mostly asymptomatic; however, primary exposure during ado-lescence manifests itself as infectious mononucleosis (IM) in 30 to 70 % of cases (3–7). It is not known why some individuals are more likely than others to develop clinical symptoms from delayed in-fection (8). While CD8T cells play a central protective role in the control of latent EBV infection, they are also likely to be the main

More like this